Low-Dose Sumatriptan for Acute Migraine
For acute migraine treatment, start with sumatriptan 25 mg orally as the low-dose option, though 50 mg provides superior efficacy with acceptable tolerability and should be considered the optimal starting dose for most patients. 1
Dosing Regimen
Initial Dosing
- Low-dose sumatriptan: 25 mg orally is FDA-approved but provides inferior efficacy compared to higher doses 1
- Preferred dose: 50 mg orally offers the best balance of efficacy and tolerability 2
- 100 mg may be used but provides minimal additional benefit over 50 mg while increasing adverse events 1, 2
Repeat Dosing
- If migraine persists or returns after initial improvement, administer a second dose at least 2 hours after the first dose 1
- Maximum daily dose: 200 mg in 24 hours 1
- Do not exceed treating more than 4 headaches per 30-day period (safety not established beyond this) 1
Route-Specific Considerations
- Subcutaneous 4-6 mg: Most effective route with fastest onset (pain-free in 59% at 2 hours with 6 mg), but higher adverse event rate 3, 4
- Intranasal 20 mg: Effective alternative when oral route compromised by nausea/vomiting 3
- Oral formulations: Most convenient but slower onset than parenteral routes 3
Clinical Algorithm
Step 1: Initial Treatment Selection
Start with NSAIDs (ibuprofen, naproxen, diclofenac) or acetaminophen for first-line therapy 5
Step 2: Add Triptan if Inadequate Response
Combine sumatriptan 50 mg with an NSAID (or acetaminophen if NSAIDs contraindicated) when initial therapy fails 5
- This combination provides superior efficacy compared to either agent alone 5
- Initiate treatment early when pain is mild for best results 5, 3
Step 3: Route Selection
- Oral route: Standard for most patients
- Subcutaneous route: When rapid relief essential or severe nausea/vomiting present 5
- Intranasal route: Alternative when oral route compromised 3
Hepatic Impairment Adjustment
Maximum single dose: 50 mg in patients with mild-to-moderate hepatic impairment 1
Critical Contraindications
- Ischemic heart disease or coronary artery vasospasm
- Cerebrovascular disease or stroke
- Peripheral vascular disease
- Uncontrolled hypertension
- Hemiplegic or basilar migraine
- Recent use (within 24 hours) of ergotamine-containing medications or other triptans
- Recent use (within 2 weeks) of MAO inhibitors
Medication Overuse Headache Prevention
Limit triptan use to ≤10 days per month to prevent medication overuse headache 5
- NSAIDs threshold: ≤15 days per month 5
- If frequent attacks occur, add preventive therapy rather than increasing acute medication frequency 5
Special Populations
Pregnancy and Lactation
- Acetaminophen is first-line during pregnancy 6
- Sumatriptan may be considered in selected pregnant patients after risk-benefit discussion 6
- Sumatriptan is compatible with breastfeeding 6
Severe Nausea/Vomiting
Use non-oral triptan formulation (subcutaneous or intranasal) plus antiemetic 5
Alternative Therapies When Sumatriptan Fails
If inadequate response to sumatriptan plus NSAID combination:
- Try different triptan (almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, zolmitriptan) - individual response varies within class 5
- CGRP antagonists (gepants): rimegepant, ubrogepant, zavegepant 5
- Ergot alkaloid: dihydroergotamine 5
- Ditan: lasmiditan (last-line option) 5
What NOT to Use
Avoid opioids and butalbital-containing compounds for acute migraine treatment 5
Key Clinical Pearls
- The 25 mg dose is technically "low-dose" but 50 mg is superior in efficacy with similar tolerability and should be the practical starting point for most patients 2
- Early treatment when pain is mild provides better outcomes than waiting for severe pain 5, 3
- Combination therapy (triptan + NSAID) is more effective than monotherapy 5
- Individual triptan response varies - failure of one triptan doesn't predict failure of others 5